Exportation of controlled substances

21 U.S. Code § 953. Exportation of controlled substances

(a) Narcotic drugs in schedule I, II, III, or IVIt shall be unlawful to export from the United States any narcotic drug in schedule I, II, III, or IV unless—
(1) it is exported to a country which is a party to—
(A)
the International Opium Convention of 1912 for the Suppression of the Abuses of Opium, Morphine, Cocaine, and Derivative Drugs, or to the International Opium Convention signed at Geneva on February 19, 1925; or
(B)
the Convention for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs concluded at Geneva, July 13, 1931, as amended by the protocol signed at Lake Success on December 11, 1946, and the protocol bringing under international control drugs outside the scope of the convention of July 13, 1931, for limiting the manufacture and regulating the distribution of narcotic drugs (as amended by the protocol signed at Lake Success on December 11, 1946), signed at Paris, November 19, 1948; or
(C)
the Single Convention on Narcotic Drugs, 1961, signed at New York, March 30, 1961;
(2)
such country has instituted and maintains, in conformity with the conventions to which it is a party, a system for the control of imports of narcotic drugs which the Attorney General deems adequate;
(3)
the narcotic drug is consigned to a holder of such permits or licenses as may be required under the laws of the country of import, and a permit or license to import such drug has been issued by the country of import;
(4)
substantial evidence is furnished to the Attorney General by the exporter that (A) the narcotic drug is to be applied exclusively to medical or scientific uses within the country of import, and (B) there is an actual need for the narcotic drug for medical or scientific uses within such country; and
(5)
a permit to export the narcotic drug in each instance has been issued by the Attorney General.
This document is only available to subscribers. Please log in or purchase access.